Hpv Vaccine Age Limit In India, Current Status Of Human Papillomavirus Vaccination In India S Cervical Cancer Prevention Efforts The Lancet Oncology

Hpv vaccine is recommended for routine vaccination at age 11 or 12 years.

Covid 19 vaccine update in india in hindi. For women over age 26 years the best way to prevent cervical cancer is to get routine cervical cancer screening as recommended. Hpv infections and cervical precancers abnormal cells on the cervix that can lead to cancer have dropped significantly since the vaccine has been in use. All the hpv vaccines used in the projects are licensed by the drug regulatory authority of india recommended by the indian academy of pediatrics the federation of obstetric and gynaecological societies of india and by the who strategic advisory group of experts on immunization and have received who prequalification after extensive review of safety and efficacy data from global clinical trials.

Hpv types 16 and 18 are responsible for about 70 of all cer vical cancer cases worldwide. Hpv vaccination is given as a series of either two or three doses depending on age at initial vaccination. Vaccination can be started at age 9 acip also recommends vaccination for everyone through age 26 years if not adequately vaccinated previously.

Hpv vaccination is not currently recommended for women over age 26 years. Vaccination can be given starting at age 9 years. Adults aged 26 years.

Collectively these types are implicated in 90 of cervical cancers. Clinical trials showed that overall hpv vaccination offered women limited or no protection against hpv related diseases. Penis as well as head and neck cancers.

Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus hpv in the genesis of cervical carcinoma is well documented. Hpv vaccines are used to prevent hpv infection and therefore cervical cancer.

The hpv 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. Hpv vaccines that prevent hpv 16 and 18 infections are now available and have the potential to reduce the incidence of cervical and other anogenital cancers. Good evidence supports that vaccination of large percentage of people within a population decreases rates of hpv infections with part of the benefit from herd immunity.

As hpv vaccine is recommended for an age group not routinely served by immunization programmes and since the population impact of the vaccine on cervical cancer cannot be measured until years after the vaccine has been introduced new approaches to monitoring coverage and impact are needed for hpv vaccine. Gardasil 9 prevents infection by the same hpv types as gardasil plus hpv 31 hpv 33 hpv 45 hpv 52 and hpv 58. Some types are recommended in the united states for women and men who are 926 years of age and are approved for those who are 2745 years of age.

Hpv vaccination is routinely recommended at age 11 or 12 years. Catch up hpv vaccination is recommended for all persons through age 26 years who are not adequately vaccinated. Hpv vaccination in this age range provides less benefit as more people have already been exposed to hpv.